Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiovascular and inflammatory signaling pathways comprise numerous interconnected molecular cascades that control immune and inflammatory responses in cardiovascular tissues. These include, but are not limited to, the NF-κB, NLRP3 inflammasome, MAPK, JAK/STAT, and toll-like receptor pathways, all of which interact to regulate cytokine production, immune cell recruitment, and cellular responses to injury and stress. These pathways are not individual therapeutic targets but rather contain many druggable nodes (e.g., cytokines such as IL-1β and TNF, receptors such as TLRs, and kinases such as JAKs), and dysregulation of these pathways is fundamental to the development and complications of cardiovascular diseases such as atherosclerosis, myocardial infarction, and heart failure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiovascular and inflammatory signaling pathways.